| Belgrade Medical Center | |
|
417 Washburn Avenue Belgrade MN 56312 | |
| (320) 254-8256 | |
| (320) 254-8257 |
| Full Name | Belgrade Medical Center |
|---|---|
| Speciality | Family Medicine |
| Location | 417 Washburn Avenue, Belgrade, Minnesota |
| Authorized Official Name and Position | Kirk Stensrud (CEO) |
| Authorized Official Contact | 3206342208 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Belgrade Medical Center 417 Washburn Avenue P.o. Box 178 Belgrade MN 56312 Ph: (320) 254-8256 | Belgrade Medical Center 417 Washburn Avenue Belgrade MN 56312 Ph: (320) 254-8256 |
| NPI Number | 1083621056 |
|---|---|
| Provider Enumeration Date | 08/02/2006 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083621056 | NPI | - | NPPES |
| 76210500 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
News Archive
The combination of cell and gene therapy is rapidly raising clinical interest, although their combination has been under investigation for several decades. This is mainly due to the availability and feasibility of clinically relevant gene delivery options. This review focuses on cell therapies for heart failure and their use combined with cardiac surgery as well as with gene therapy.
A group of researchers led by Mayo Clinic has discovered that disclosing genetic risk for coronary heart disease (CHD) results in lower low-density lipoprotein cholesterol (LDL), also known as bad cholesterol. The findings of the Myocardial Infarction Genes (MI-GENES) Study were presented today at the annual American Heart Association Scientific Sessions 2015 as a late-breaking clinical trial.
Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology at LSU Health Sciences Center New Orleans, showing that a single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, will be published in the June 12, 2009 online issue of PLoS Pathogens.
Six-month results from the DELUX registry and 12-month results from the PEPPER study, both demonstrating excellent safety and efficacy results for the Pantera Lux Paclitaxel Releasing Balloon, were presented on Tuesday and Wednesday at the Transcatheter Cardiovascular Therapeutics (TCT 2011) conference by Dr. Ralph Toelg, MD, Segeberger Heart Center Clinic, Bad Segeberg, Germany, and Prof. Christoph Hehrlein, MD, University Medical Center, Freiburg, Germany, respectively.
› Verified 6 days ago
Centracare Health Paynesville - Belgrade Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 505 Nelson Ave, Belgrade, MN 56312 Phone: 320-254-8241 Fax: 320-254-3771 |